Delivery Order SPE2DE24DA017-SPE2D625F9X9P
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order on August 15, 2025, valued at $19,459.80 for DX Fibertak Suture Anchor, #2 MTS with needle. This fixed-price delivery order with economic price adjustment is set to be completed by August 20, 2025, and will be performed in Naples, Florida. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency supporting the...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $16,460.86 on September 3, 2025, for DX Fibertak Suture Anchor products with sterile needles. This fixed-price contract with economic price adjustment carries an ultimate completion date of September 9, 2025, and will be performed in Naples, Florida. The award was made by the Defense Logistics Agency's Medical Supply Chain, a...
- Arthrex Inc., headquartered in Naples, Florida, was awarded a delivery order valued at $15,435.11 on September 19, 2025, by the Defense Logistics Agency's Medical Supply Chain for DX Fibertak Suture Anchor products, size #2 with needle. This fixed-price delivery order with economic price adjustment was issued without set-aside designation and is scheduled for completion by September 24, 2025, with performance occurring in Naples, Florida. The award represents another task order under Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,274.20 on August 7, 2025, for DX Fibertak Suture Anchor #2 MTS with needle. This fixed-price delivery order with economic price adjustment is expected to be completed by August 21, 2025, and will be performed in Naples, Florida. The award was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-oriented procurement vehicle supporting...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $4,346.70 for DX Fibertak Suture Anchor, #2 MTS with needle on September 12, 2025. This fixed-price delivery order with economic price adjustment is scheduled for completion by September 17, 2025, and will be performed in Naples, Florida. The award was issued under a non-set-aside competitive procurement by the Defense Logistics Agency's Medical Supply Chain,...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $6,470.97 for DX Fibertak Suture Anchor, #2 MTS with needle on August 25, 2025. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for distributing medical supplies to Department of Defense and Department of Veterans...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, was awarded a fixed-price delivery order valued at $10,053.70 on May 15, 2025, for DX Fibertak Suture Anchor #2 MTS with needle. The contract, which is not set aside for any specific business type, will be performed in Naples, Florida, with an ultimate completion date of May 20, 2025. This delivery order falls under the Defense Logistics Agency's Medical Supply Chain program and leverages Arthrex's broader Indefinite...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,274.20 on July 22, 2025, for DX Fibertak Suture Anchor, #2 MTS with needle. This fixed-price delivery order with economic price adjustment represents a task order issued under Arthrex's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Medical Supply Chain, valued at approximately $471 million and running through September 1,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order award valued at $3,274.20 from the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. The contract calls for delivery of DX Fibertak Suture Anchor, #2 MTS with needle, with an ultimate completion date of September 11, 2025. This fixed-price delivery order with economic price adjustment was awarded without set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a leading developer and manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $8,089.62 by the Defense Logistics Agency's Medical Supply Chain on July 10, 2025. The contract covers DX Fibertak Suture Anchor, #1 FW & Needles, a specialized orthopedic surgical product used in arthroscopic repair procedures. This fixed-price delivery order with economic price adjustment features an ultimate...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F9X9PDelivery Order
Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order on May 30, 2025, for DX Fibertak Suture Anchor #2 MTS with needle. This fixed-price delivery order, valued at $5,146.25 with economic price adjustment provisions, is set to be completed by June 4, 2025, and will be performed in Naples, FL. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a defense agency responsible for supplying medical equipment and devices to military and veteran healthcare systems. This delivery order falls under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471 million and running through September 1, 2029. The Fibertak suture anchor system represents one of Arthrex's specialized orthopedic surgical implant offerings, which are routinely procured by Veterans Affairs medical centers and Department of Defense facilities nationwide. As a competitive award with no set-aside designation, this order demonstrates Arthrex's established capability and market position in supplying advanced orthopedic technologies to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 5/30/25 |